JAC Advance Access published online on May 9, 2005
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dki146
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Microbiology, Papworth Hospital, Papworth Everard, Cambridge CB3 8RE, UK
* To whom correspondence should be addressed. Objectives: To investigate the variability in antimicrobial susceptibility of Pseudomonas aeruginosa from sputa of patients with cystic fibrosis, to compare testing individual colonies of the same morphotype either separately or combined and to study the reproducibility of testing antimicrobial susceptibility within and between laboratories. Methods: One hundred and one sputa were cultured. Four colonies of each P. aeruginosa morphotype were suspended. Susceptibility to 12 agents by disc diffusion was tested individually or by pooling the four suspensions. A sputum sample containing four morphotypes of one genotype of P. aeruginosa was used to study reproducibility. Susceptibility was tested in duplicate by eight biomedical scientists in one laboratory and by routine procedures in seven different laboratories. Results: There was a mean of four morphotypes of P. aeruginosa per sputum and three antibiograms per morphotype. In some cases, all four colonies of a single morphotype had different antibiograms. The susceptibility profiles of single isolates of P. aeruginosa correlated poorly with pooled cultures, with the pooled tests missing resistance. Results from one sample tested in duplicate by eight biomedical scientists in one laboratory and in seven other laboratories did not correlate well. The wide range of zone sizes in disc diffusion tests illustrated the variation in susceptibility of 48 colonies from one sputum sample. Conclusions: The role of conventional antimicrobial susceptibility testing is questionable once P. aeruginosa chronically infects the cystic fibrosis lung. A range of susceptibility patterns is seen, even within a morphotype. Routine test results are not reproducible and underestimate resistance.
Received January 10, 2005
Revised March 23, 2005
Accepted April 5, 2005
Original article
Phenotypic variability of Pseudomonas aeruginosa in sputa from patients with acute infective exacerbation of cystic fibrosis and its impact on the validity of antimicrobial susceptibility testing
2 Health Protection Agency, Clinical Microbiology and Public Health Laboratory, Addenbrooke's Hospital, Cambridge CB2 2QW, UK
3 Department of Chest Medicine, Papworth Hospital, Papworth Everard, Cambridge CB3 8RE, UK
J. E. Foweraker, E-mail: juliet.foweraker{at}papworth.nhs.uk
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. E. Foweraker, C. R. Laughton, D. F. Brown, and D. Bilton Comparison of Methods To Test Antibiotic Combinations against Heterogeneous Populations of Multiresistant Pseudomonas aeruginosa from Patients with Acute Infective Exacerbations in Cystic Fibrosis Antimicrob. Agents Chemother., November 1, 2009; 53(11): 4809 - 4815. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. E. N. Milne and I. M. Gould Combination testing of multidrug-resistant cystic fibrosis isolates of Pseudomonas aeruginosa: use of a new parameter, the susceptible breakpoint index J. Antimicrob. Chemother., October 27, 2009; (2009) dkp384v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Vettoretti, P. Plesiat, C. Muller, F. El Garch, G. Phan, I. Attree, A. Ducruix, and C. Llanes Efflux Unbalance in Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients Antimicrob. Agents Chemother., May 1, 2009; 53(5): 1987 - 1997. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. I. Gillham, S. Sundaram, C. R. Laughton, C. S. Haworth, D. Bilton, and J. E. Foweraker Variable antibiotic susceptibility in populations of Pseudomonas aeruginosa infecting patients with bronchiectasis J. Antimicrob. Chemother., April 1, 2009; 63(4): 728 - 732. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Foweraker Recent advances in the microbiology of respiratory tract infection in cystic fibrosis Br. Med. Bull., March 1, 2009; 89(1): 93 - 110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Dai, G. P. Tegos, M. Burkatovskaya, A. P. Castano, and M. R. Hamblin Chitosan Acetate Bandage as a Topical Antimicrobial Dressing for Infected Burns Antimicrob. Agents Chemother., February 1, 2009; 53(2): 393 - 400. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Waine, D. Honeybourne, E. G. Smith, J. L. Whitehouse, and C. G. Dowson Association between Hypermutator Phenotype, Clinical Variables, Mucoid Phenotype, and Antimicrobial Resistance in Pseudomonas aeruginosa J. Clin. Microbiol., October 1, 2008; 46(10): 3491 - 3493. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Ryall, J. C. Davies, R. Wilson, A. Shoemark, and H. D. Williams Pseudomonas aeruginosa, cyanide accumulation and lung function in CF and non-CF bronchiectasis patients Eur. Respir. J., September 1, 2008; 32(3): 740 - 747. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Perry, L. Laine, S. Hughes, A. Nicholson, A. Galloway, and F. K. Gould Recovery of antimicrobial-resistant Pseudomonas aeruginosa from sputa of cystic fibrosis patients by culture on selective media J. Antimicrob. Chemother., May 1, 2008; 61(5): 1057 - 1061. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Etherington, M. Hall, S. Conway, D. Peckham, and M. Denton Clinical impact of reducing routine susceptibility testing in chronic Pseudomonas aeruginosa infections in cystic fibrosis J. Antimicrob. Chemother., February 1, 2008; 61(2): 425 - 427. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Kirov, J. S. Webb, C. Y. O'May, D. W. Reid, J. K. K. Woo, S. A. Rice, and S. Kjelleberg Biofilm differentiation and dispersal in mucoid Pseudomonas aeruginosa isolates from patients with cystic fibrosis Microbiology, October 1, 2007; 153(10): 3264 - 3274. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Merlo, M. P. Boyle, M. Diener-West, B. C. Marshall, C. H. Goss, and N. Lechtzin Incidence and Risk Factors for Multiple Antibiotic-Resistant Pseudomonas aeruginosa in Cystic Fibrosis Chest, August 1, 2007; 132(2): 562 - 568. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. St. Denis, K. Ramotar, K. Vandemheen, E. Tullis, W. Ferris, F. Chan, C. Lee, R. Slinger, and S. D. Aaron Infection With Burkholderia cepacia Complex Bacteria and Pulmonary Exacerbations of Cystic Fibrosis Chest, April 1, 2007; 131(4): 1188 - 1196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. W. Govan Multidrug-resistant pulmonary infection in cystic fibrosis - what does 'resistant' mean? J. Med. Microbiol., December 1, 2006; 55(Pt 12): 1615 - 1617. [Full Text] [PDF]
|
|